Medical therapies for meningiomas.
Meningiomas are the most common primary brain tumor in adults. Although the majority of these tumors can be effectively treated with surgery and radiation therapy, an important subset of patients have inoperable tumors, or develop recurrent disease after surgery and radiotherapy, and require some form of medical therapy. There are increasing numbers of studies evaluating various medical therapies but the results remain disappointing. Chemotherapies and hormonal therapies have been generally ineffective, although somatostatin analogues may have therapeutic potential. There is also increasing interest in targeted molecular therapies. Agents inhibiting platelet derived growth factor receptors and epidermal growth factor receptors have shown little efficacy, but molecular agents inhibiting vascular endothelial growth factor receptors appear to have some promise. As with other tumors, advances in the medical therapies for meningiomas will require improved understanding of the molecular pathogenesis of these tumors, more predictive preclinical models, and efficient mechanisms for conducting clinical trials, given the small population of eligible patients.
Wen
Patrick Y
PY
Center for Neuro-Oncology, Department of Medical Oncology, Dana-Farber/Brigham and Women's Cancer Center, Boston, MA 02115, USA. pwen@partners.org
Quant
Eudocia
E
Drappatz
Jan
J
Beroukhim
Rameen
R
Norden
Andrew D
AD
D000970:Antineoplastic Agents / Q000627:therapeutic use*; D016371:Cranial Irradiation; D006801:Humans; D008577:Meningeal Neoplasms / Q000628:therapy*; D008579:Meningioma / Q000628:therapy*; D016634:Radiosurgery
D000970:Antineoplastic Agents
Cancer Cell. 2002 Sep;2(3):183-92
12242151
J Clin Oncol. 2005 Apr 1;23(10):2411-22
15800333
Nat Rev Cancer. 2005 Jul;5(7):505-15
16069815
Neurosurgery. 1997 Jun;40(6):1269-77
9179901
Clin Cancer Res. 2001 Aug;7(8):2269-76
11489801
Int J Oncol. 2006 Jul;29(1):25-32
16773181
J Neurooncol. 2002 Mar;57(1):19-26
12125963
Curr Neurol Neurosci Rep. 2009 May;9(3):231-40
19348712
Nature. 2005 Jun 2;435(7042):677-81
15902208
J Clin Oncol. 2009 Oct 1;27(28):4733-40
19720927
Br J Neurosurg. 2004 Oct;18(5):495-9
15799152
J Neuropathol Exp Neurol. 2005 Dec;64(12):1029-36
16319713
J Neurosurg. 2008 Feb;108(2):304-10
18240927
Neurosurgery. 1997 May;40(5):1016-26
9149260
J Cardiovasc Pharmacol. 2000 Nov;36(5 Suppl 1):S135-9
11078359
Cancer Res. 1997 Jul 1;57(13):2611-4
9205065
Expert Rev Anticancer Ther. 2005 Apr;5(2):355-78
15877531
J Neurooncol. 1996 Sep;29(3):207-16
8858526
J Neurosurg. 2001 Mar;94(3):487-92
11235955
Cancer Control. 2003 Mar-Apr;10(2):148-58
12712009
J Neurooncol. 2008 Jan;86(1):109-22
17624496
Neurosurgery. 2007 Apr;60(4):750-9; discussion 759-60
17415213
Cancer Cell. 2004 Dec;6(6):553-63
15607960
Nat Rev Cancer. 2009 Aug;9(8):550-62
19629070
Neuropathol Appl Neurobiol. 1998 Dec;24(6):441-52
9888154
J Neurooncol. 1997 Dec;35(3):289-301
9440026
Front Biosci (Elite Ed). 2009 Jun 01;1:494-500
19482663
J Neurosurg. 1999 Sep;91(3):440-6
10470819
CA Cancer J Clin. 2010 Jul-Aug;60(4):222-43
20554717
Curr Treat Options Oncol. 2004 Dec;5(6):499-509
15509483
Cancer Chemother Biol Response Modif. 2005;22:123-33
16110610
Crit Rev Oncol Hematol. 2008 Aug;67(2):153-71
18342535
Genes Dev. 2002 May 1;16(9):1060-5
12000789
Neurosurgery. 2007 May;60(5):787-98; discussion 787-98
17460514
Expert Rev Anticancer Ther. 2006 May;6(5):679-95
16759160
J Neurooncol. 2004 Jan;66(1-2):155-66
15015781
Cancer Genet Cytogenet. 2008 Nov;187(1):25-7
18992637
J Nucl Med. 1998 Nov;39(11):1913-7
9829583
J Neurosurg. 1997 Aug;87(2):315-23
9254099
J Neuropathol Exp Neurol. 2004 Apr;63(4):275-86
15099018
Cancer Treat Rev. 2006 May;32(3):157-65
16516391
J Clin Oncol. 2010 Feb 20;28(6):1075-83
20085938
Expert Rev Mol Diagn. 2006 Jul;6(4):613-26
16824034
Cancer. 2008 Oct 15;113(8):2146-51
18756531
J Neurooncol. 2004 Jan;66(1-2):9-16
15015765
Nat Rev Cancer. 2005 Apr;5(4):297-309
15803156
Cancer. 1990 Jul 1;66(1):152-5
2354402
Neurosurg Focus. 2007;23(4):E11
17961035
Expert Opin Investig Drugs. 2008 Aug;17(8):1225-35
18616418
J Neurooncol. 2004 Mar-Apr;67(1-2):221-6
15072471
Neurology. 1975 Aug;25(8):705-12
1171403
Neurosurg Focus. 2007;23(4):E10
17961034
J Neurooncol. 2014 Mar;117(1):93-101
24449400
Int J Oncol. 2003 Feb;22(2):289-94
12527924
J Neurosurg. 1996 May;84(5):733-6
8622144
Brain Pathol. 2008 Apr;18(2):172-9
18093250
J Neurosurg. 2000 Feb;92(2):306-14
10659019
Brain Pathol. 2008 Jan;18(1):62-70
17924978
J Neurosurg. 1997 May;86(5):845-52
9126901
Lancet Neurol. 2006 Dec;5(12):1045-54
17110285
Neurosurg Focus. 2007;23(4):E9
17961046
J Neurooncol. 2004 Nov;70(2):183-202
15674477
Neurology. 2004 Apr 13;62(7):1210-2
15079029
J Neurosurg. 2007 Mar;106(3):455-62
17367069
Hum Reprod. 1994 Jun;9 Suppl 1:202-7
7962466
Surg Gynecol Obstet. 1993 Nov;177(5):488-96
8211601
Cancer Epidemiol Biomarkers Prev. 2008 Oct;17(10):2663-70
18843008
J Neurosurg. 2002 Sep;97(3):668-75
12296652
Cancer Lett. 2004 Sep 15;213(1):117-24
15312691
Am J Clin Oncol. 2009 Feb;32(1):73-85
19194129
Nat Rev Cancer. 2003 Jul;3(7):489-501
12835669
Neurosurgery. 2000 Nov;47(5):1185-95
11063113
Acta Neuropathol. 2004 Aug;108(2):135-42
15148612
J Clin Oncol. 2005 Dec 20;23(36):9394-407
16361639
J Clin Oncol. 2008 Jan 10;26(2):279-82
18182668
J Neurooncol. 1993 Jan;15(1):75-7
8455065
Neurosurgery. 2005 Sep;57(3):538-50; discussion 538-50
16145534
Int J Cancer. 2005 Dec 20;117(6):996-1001
15986431
J Neurosurg. 2007 Jun;106(6):1034-40
17564176
Int J Cancer. 1990 Nov 15;46(5):772-8
1699901
J Clin Neurosci. 2001 May;8 Suppl 1:49-53
11386826
Surg Neurol. 1985 Sep;24(3):245-9
4023903
Eur J Endocrinol. 2002 May;146(5):707-16
11980628
J Neurooncol. 1996 Sep;29(3):269-72
8858533
Int J Cancer. 1990 Jul 15;46(1):16-21
2163990
Endocr Relat Cancer. 2008 Dec;15(4):931-41
18632875
Oncogene. 2008 Oct 20;27(48):6252-75
18931692
Cancer Treat Rev. 2006 Oct;32(6):407-16
16889900
Cancer Invest. 2006 Dec;24(8):727-33
17162554
J Clin Oncol. 2007 Sep 10;25(26):4033-42
17827451
Neuroimaging Clin N Am. 2010 Aug;20(3):425-48
20708556
J Neurol Neurosurg Psychiatry. 1992 Jun;55(6):486-90
1619417
CA Cancer J Clin. 2005 May-Jun;55(3):178-94
15890640
J Nucl Med. 2005 May;46(5):763-9
15872348
J Neurosurg. 1998 May;88(5):938-9
9576275
Nat Rev Cancer. 2008 Oct;8(10):782-98
18813321
J Neurosurg. 1997 Jan;86(1):113-20
8988089
Lancet. 2004 May 8;363(9420):1535-43
15135603
Expert Opin Ther Targets. 2007 Jan;11(1):91-100
17150037
Expert Rev Neurother. 2006 Oct;6(10):1447-64
17078786
Expert Rev Anticancer Ther. 2005 Apr;5(2):333-42
15877529
J Pathol. 1999 Sep;189(1):66-71
10451490
Nat Rev Cancer. 2008 Feb;8(2):121-32
18202696
Hum Pathol. 1994 Feb;25(2):146-53
8119714
J Neurosurg. 2001 Nov;95(5):839-44
11702875
Clin Cancer Res. 2005 Jun 1;11(11):4074-82
15930342
J Neurosurg. 2001 Feb;94(2):293-300
11213968
Cancer Res. 2005 Feb 15;65(4):1547-53
15735044
J Neurosurg Sci. 1993 Dec;37(4):237-41
7931648
J Neurooncol. 2006 Jul;78(3):271-6
16628476
Acta Neurochir (Wien). 2000;142(5):493-505
10898356
J Neurooncol. 2010 Jan;96(2):211-7
19562255
Cancer Biol Ther. 2004 Mar;3(3):247-50
15107611
Cancer. 2007 Aug 1;110(3):471-6
17580362
Neurosurgery. 1998 Oct;43(4):890-8; discussion 898-9
9766317
J Neurooncol. 1995;23(1):23-9
7542695
BMC Cancer. 2006 Jun 07;6:152
16759391
Curr Drug Targets. 2010 Mar;11(3):291-302
20210754
J Neurosurg. 1997 May;86(5):840-4
9126900
Neuro Oncol. 2009 Dec;11(6):853-60
19293394
Int J Oncol. 2008 Nov;33(5):937-47
18949356
J Clin Neurosci. 2002 Mar;9(2):156-8
11922703
J Clin Oncol. 2006 Apr 10;24(11):1770-83
16603719
Skull Base. 2008 May;18(3):173-87
18978964
Neurosurg Rev. 2004 Oct;27(4):238-45
15168138
N Engl J Med. 2008 May 8;358(19):2039-49
18463380
Curr Treat Options Neurol. 2004 Jul;6(4):297-305
15157407
Oncology (Williston Park). 2004 Nov;18(13 Suppl 10):5-10
15651171
Brain Tumor Pathol. 2001;18(1):1-5
11517968
J Clin Invest. 1995 Oct;96(4):2017-25
7560095
J Neurooncol. 1995 Oct;26(1):45-51
8583244
Acta Oncol. 2010 Aug;49(6):872-4
20429732
Neurosurgery. 2000 Apr;46(4):938-47; discussion 947-8
10764269
J Neurosurg. 2002 Aug;97(2):341-6
12186462
J Neurosurg. 1991 Jun;74(6):861-6
2033444
J Neurosurg. 1996 May;84(5):852-8; discussion 858-9
8622161
Neurosurg Clin N Am. 2006 Apr;17(2):111-20, vi
16793503
N Engl J Med. 2007 Dec 6;357(23):2411-2
18057351
Eur J Endocrinol. 2005 Jan;152(1):161-2
15762200
Ann Oncol. 2001;12 Suppl 2:S131-4
11762340
Expert Rev Neurother. 2004 Jul;4(4):641-8
15853583
J Neurooncol. 2009 Mar;92(1):1-6
19023520
Cell Mol Life Sci. 2007 Feb;64(4):458-78
17260089
Eur J Cancer. 1991;27(4):416-9
1828169
Cancer Res. 1987 Apr 15;47(8):2172-6
3493842
Neurology. 2007 Sep 4;69(10):969-73
17785665
Clin Cancer Res. 2003 Sep 1;9(10 Pt 1):3749-55
14506167
Hybridoma. 2001 Apr;20(2):131-6
11394532
Neurosurgery. 1997 Feb;40(2):271-5
9007858
Neurology. 2004 Sep 28;63(6):1133-4
15452322